Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Imunon, Inc. (IMNN)

0.8766
+0.0046
+(0.53%)
At close: April 23 at 4:00:00 PM EDT
0.8899
-0.01
(-0.90%)
Pre-Market: 8:00:02 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
500
500
Operating Expense
19,132.4460
19,132.4460
21,030.4300
25,421.5650
21,507.1900
Operating Income
-19,132.4460
-19,132.4460
-21,030.4300
-24,921.5650
-21,007.1900
Net Non Operating Interest Income Expense
450.2210
450.2210
528.7440
-4,526.0400
-551.7360
Other Income Expense
61.9830
61.9830
-293.6760
-8,017.6550
-593.7700
Pretax Income
-18,620.2420
-18,620.2420
-20,795.3620
-37,465.2600
-22,152.6960
Tax Provision
--
--
-1,280.3850
-1,567.0260
-1,383.4460
Net Income Common Stockholders
-18,620.2420
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Diluted NI Available to Com Stockholders
-18,620.2420
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Basic EPS
-1.62
-1.62
-2.16
-5.03
-3.83
Diluted EPS
-1.62
-1.62
-2.16
-5.03
-3.83
Basic Average Shares
11,508.1590
11,508.1590
9,045.3200
7,143
5,424.3140
Diluted Average Shares
11,508.1590
11,508.1590
9,045.3200
7,143
5,424.3140
Total Operating Income as Reported
-19,132.4460
-19,132.4460
-21,030.4300
-24,921.5650
-21,007.1900
Total Expenses
19,132.4460
19,132.4460
21,030.4300
25,421.5650
21,507.1900
Net Income from Continuing & Discontinued Operation
-18,620.2420
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Normalized Income
-18,682.2250
-18,682.2250
-19,611.3588
-28,207.5757
-20,210.5125
Interest Income
450.2210
450.2210
725.8240
502.5780
18.1450
Interest Expense
--
--
197.0800
5,028.6180
569.8810
Net Interest Income
450.2210
450.2210
528.7440
-4,526.0400
-551.7360
EBIT
-18,620.2420
-18,620.2420
-20,598.2820
-32,436.6420
-21,582.8150
EBITDA
-17,902.1260
-17,902.1260
-19,878.2770
-31,705.0130
-20,879.8970
Reconciled Depreciation
718.1160
718.1160
720.0050
731.6290
702.9180
Net Income from Continuing Operation Net Minority Interest
-18,620.2420
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Total Unusual Items Excluding Goodwill
61.9830
61.9830
102.6430
-8,019.4560
-595.6690
Total Unusual Items
61.9830
61.9830
102.6430
-8,019.4560
-595.6690
Normalized EBITDA
-17,964.1090
-17,964.1090
-19,980.9200
-23,685.5570
-20,284.2280
Tax Rate for Calcs
--
--
0.0001
0
0.0001
Tax Effect of Unusual Items
--
--
6.2612
-328.7977
-36.9315
12/31/2021 - 3/1/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XLO Xilio Therapeutics, Inc.
0.7939
-1.99%
 
RNTX Rein Therapeutics Inc.
1.8600
+0.54%
 
IMNM Immunome, Inc.
8.50
+3.79%
 
IMTX Immatics N.V.
4.5100
+4.40%
 
CMMB Chemomab Therapeutics Ltd.
1.2000
+2.56%
 
CMPX Compass Therapeutics, Inc.
2.0700
+4.55%
 
CLDX Celldex Therapeutics, Inc.
19.43
+0.21%
 
ACHV Achieve Life Sciences, Inc.
2.4300
-2.02%
 
INZY Inozyme Pharma, Inc.
0.9806
-4.80%
 
HNSA.ST Hansa Biopharma AB (publ)
24.02
+7.71%